Skip to main content

People in the News: Phillip Maples, Catherine Moukheibir

Premium

Gradalis has promoted Phillip Maples as executive vice president and chief technical officer.

Maples joined the company as its first employee in 2005, and in his new role will continue to oversee product development, manufacturing, and quality assurance.

Before Gradalis, Maples held various roles at Baxter Healthcare, US Oncology, and CellExSys.


Therapeutic protein developer Ablnyx has appointed Catherine Moukheibir it is board of directors.

Moukheibir is currently a board member of Innate Pharma and an independent director of Creabilis. She previously served as vice president of Spanish RNAi drug developer Sylentis.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.